inflammatory factors

炎症因子
  • 文章类型: Journal Article
    Allergic rhinitis (AR) is a nasal hypersensitivity disease that is influenced by environmental factors, genetic factors, and various inflammatory factors. The role and mechanisms of ozone, as a component of air pollution, in the pathogenesis of AR are not yet fully understood. This article provides a review of the impact of ozone on the epidemiology and pathology of AR, as well as its possible mechanisms, to provide new insights into the prevention and treatment of AR.
    摘要: 变应性鼻炎(AR)是由环境因素和遗传因素及多种炎性因子共同参与的鼻部变态反应性疾病。其中,臭氧作为大气污染参与AR发病的病理过程及作用机制尚不十分清楚。本文就臭氧对AR流行病学的影响、病理学影响及其可能的作用机制进行综述,为AR的防治提供新的思路。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    观察性研究已将自身免疫性疾病(AD)与鼻窦炎(RS)表现联系起来。建立AD和RS之间的因果关系,探讨炎症介质在AD和RS之间的潜在中介作用,我们利用孟德尔随机化(MR)分析.使用双样本MR方法,我们检查了多发性硬化症(MS)之间的因果关系,类风湿性关节炎(RA),强直性脊柱炎(AS),牛皮癣(PsO),1型糖尿病(T1D),干燥综合征(SS),乳糜泻(CeD),克罗恩病(CD),甲状腺功能减退症(HT),严重疾病(GD),和桥本甲状腺炎及其与慢性和急性鼻-鼻窦炎(CRS和ARS,分别)。为了实现这一点,我们采用了三种不同的MR技术:方差逆加权(IVW),MR-Egger,和加权中位数法。我们的分析还包括各种敏感性评估,例如Cochran的Q测试,遗漏分析,MR-Egger截获,和MR-PRESSO,以确保我们研究结果的稳健性。此外,该研究通过全面的两步MR分析探索了炎症蛋白在这些关系中作为介质的作用.在广告中,MS,RA,T1D,CeD,和HT被确定为CRS的危险因素。只有CeD表现出与ARS的因果关系。随后的分析确定白细胞介素-10(IL-10)是MS关联的潜在介质,RA和HT与CRS,分别。,发现C-X-C基序趋化因子10水平(CXCL10)和T细胞表面糖蛋白CD6同工型水平(CD6)影响HT对CRS的作用。我们的发现证明了特异性自身免疫性疾病和鼻窦炎之间的因果关系。强调IL-10、CXCL10和CD6是这种关联的潜在介质。
    Observational studies have linked autoimmune diseases (ADs) with rhinosinusitis (RS) manifestations. To establish a causal relationship between ADs and RS, and to explore the potential mediating role of inflammatory mediators between ADs and RS, we utilized Mendelian randomization (MR) analysis. Using a two-sample MR methodology, we examined the causality between multiple sclerosis (MS), rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriasis (PsO), type 1 diabetes (T1D), Sjogren\'s syndrome (SS), celiac disease (CeD), Crohn\'s disease (CD), hypothyroidism (HT), Graves\' disease (GD), and Hashimoto\'s thyroiditis and their association with chronic and acute rhinosinusitis (CRS and ARS, respectively).To achieve this, we employed three distinct MR techniques: inverse variance weighting (IVW), MR-Egger, and the weighted median method. Our analysis also included a variety of sensitivity assessments, such as Cochran\'s Q test, leave-one-out analysis, MR-Egger intercept, and MR-PRESSO, to ensure the robustness of our findings. Additionally, the study explored the role of inflammation proteins as a mediator in these relationships through a comprehensive two-step MR analysis. Among the ADs, MS, RA, T1D, CeD, and HT were determined as risk factors for CRS. Only CeD exhibited a causal relationship with ARS. Subsequent analyses identified interleukin-10 (IL-10) as a potential mediator for the association of MS, RA and HT with CRS, respectively., while C-X-C motif chemokine 10 levels (CXCL10) and T-cell surface glycoprotein CD6 isoform levels (CD6) were found to influence HT\'s effect on CRS. Our findings demonstrate a causative link between specific autoimmune diseases and rhinosinusitis, highlighting IL-10, CXCL10, and CD6 as potential mediators in this association.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    阻塞性睡眠呼吸暂停(OSA)患者通常经历高抑郁率。这项研究旨在检查OSA和患有共病的重度抑郁症(OSAMDD)患者的口腔微生物群特征。
    参与者于2022年8月至2023年4月注册。多导睡眠图,精神病医生访谈,并采用量表诊断OSA和MDD。通过在颊粘膜上擦拭子从参与者那里收集口腔样本,腭,和牙龈。通过全基因组宏基因组学和测序后的生物信息学分析来分析口腔微生物群。抽取静脉血检测血浆炎症因子水平。
    该研究招募了33名OSA患者,28名OSA+MDD患者,和28个健康对照。在8个门中发现了显着差异,229属,三组中有700种口腔微生物群。OSA和OSAMDD组的Prevotellaceae丰度明显低于健康对照组。线性判别分析效应大小(LEfSe)分析表明,链球菌科和放线菌是OSA和OSA+MDD组的特征口腔菌群,分别。KEGG分析表明,与健康对照组相比,OSA和OSAMDD组的30条途径发生了变化。与OSA+MDD组相比,OSA组改变了23条通路。OSA+MDD组IL-6水平明显高于健康组,与Schaalia的丰富呈正相关,弯曲杆菌,梭杆菌,Alloprevotella,和口腔中的念珠菌纳米细菌,以及汉密尔顿焦虑量表和汉密尔顿抑郁量表评分。
    观察到三组之间口腔微生物群种群和基因功能的显着差异。OSA患者的特征是Prevotellaceae的丰度降低和链球菌科的丰度增加。OSA+MDD患者的放线菌丰度增加。IL-6可能调控OSA+MDD患者抑郁与口腔菌群的关系。
    UNASSIGNED: Obstructive sleep apnea (OSA) patients commonly experience high rates of depression. This study aims to examine the oral microbiota characteristics of OSA and those with comorbid major depressive disorder (OSA+MDD) patients.
    UNASSIGNED: Participants were enrolled from Aug 2022 to Apr 2023. Polysomnography, psychiatrist interviews, and scales were used to diagnose OSA and MDD. Oral samples were collected from participants by rubbing swabs on buccal mucosa, palate, and gums. Oral microbiota was analyzed via whole-genome metagenomics and bioinformatic analysis followed sequencing. Venous blood was drawn to detect plasma inflammatory factor levels.
    UNASSIGNED: The study enrolled 33 OSA patients, 28 OSA+MDD patients, and 28 healthy controls. Significant differences were found in 8 phyla, 229 genera, and 700 species of oral microbiota among the three groups. Prevotellaceae abundance in the OSA and OSA+MDD groups was significantly lower than that in healthy controls. Linear discriminant analysis effect size (LEfSe) analysis showed that Streptococcaceae and Actinobacteria were the characteristic oral microbiota of the OSA and OSA+MDD groups, respectively. KEGG analysis indicates 30 pathways were changed in the OSA and OSA+MDD groups compared with healthy controls, and 23 pathways were changed in the OSA group compared with the OSA+MDD group. Levels of IL-6 in the OSA+MDD group were significantly higher than in the healthy group, correlating positively with the abundance of Schaalia, Campylobacter, Fusobacterium, Alloprevotella, and Candidatus Nanosynbacter in the oral, as well as with Hamilton Anxiety Rating Scale and Hamilton Depression Rating Scale scores.
    UNASSIGNED: Significant differences in oral microbiota populations and gene function were observed among the three groups. OSA patients were characterized by a decreased abundance of Prevotellaceae and an increased abundance of Streptococcaceae. OSA+MDD patients had an increased abundance of Actinobacteria. IL-6 might regulate the relationship between depression and the oral microbiota in OSA+MDD patients.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:研究胰高血糖素样肽-1(GLP-1)受体激动剂Exendin-4对雄性ApoE-/-小鼠髓源性抑制细胞(MDSCs)比例的影响,研究血浆和脾脏组织中炎症因子浓度的变化,并评估其与MDSCs的相关性。
    方法:30只雄性ApoE-/-小鼠随机分为5组(每组6只):对照组(CON)。模型组(MOD),Exendin-4干预组(MOD/Ex-4),Exendin-9-39干预组(MOD/Ex-9-39),和Exendin-4+Exendin-9-39联合干预组(MOD/Ex-4+Ex-9-39)。药物干预4周后,使用油红O染色和H&E染色观察主动脉斑块的变化。采用流式细胞术检测骨髓和外周血中髓源性抑制细胞(MDSC)的含量。采用ELISA法检测小鼠外周血血浆中炎症因子的浓度,而RT-qPCR用于定量脾脏中炎症因子的表达水平。采用Pearson相关分析评估MDSCs与炎症因子的关系。
    结果:MOD组小鼠的体重明显高于CON组,差异具有统计学意义(P<0.05)。在Exendin-4干预之后,与MOD组相比,体重降低(P<0.05)。此外,与MOD组相比,Exendin-4治疗导致动脉粥样硬化斑块显著减少(P<0.001)。Exendin-4干预后,骨髓中MDSCs的比例高于MOD组(P<0.001),MDSCs在外周血中的比例显著高于MOD组(P<0.05)。进一步的研究表明,Exendin-4可以调节小鼠的血脂水平,降低TG浓度(P<0.01),TC(P<0.0001),和LDL-C(P<0.0001),同时增加HDL-C浓度(P<0.01)。此外,Exendin-4治疗后,外周血细胞因子IL-6水平显著低于MOD组(P<0.0001),而IL-10和TGF-β水平明显高于MOD组(P<0.0001)。在脾脏里,与MOD组相比,细胞因子IL-10(P<0.0001)和TGF-β(P<0.001)的水平显着增加。Pearson相关性分析显示,外周血中MDSCs比例与脾脏和外周血中IL-10、TGF-β水平均呈正相关。此外,骨髓中MDSCs的比例与脾脏和外周血中IL-10和TGF-β水平呈正相关。
    结论:Exendin-4可减轻动脉粥样硬化的严重程度。该过程可以通过促进动脉粥样硬化ApoE-/-小鼠骨髓和外周血中骨髓来源的抑制细胞(MDSC)的分泌来实现。调节体内炎症因子的比例,减轻老鼠的体重,降低血脂。
    OBJECTIVE: To investigate the impact of the glucagon-like peptide-1 (GLP-1) receptor agonist Exendin-4 on the proportion of myeloid-derived suppressor cells (MDSCs) in male ApoE-/- mice, and investigate alterations in the concentrations of inflammatory factors in plasma and spleen tissues and assess their correlation with MDSCs.
    METHODS: Thirty male ApoE-/- mice were randomly divided into five groups (n = 6 per group): control group (CON), model group (MOD), Exendin-4 intervention group (MOD/Ex-4), Exendin-9-39 intervention group (MOD/Ex-9-39), and Exendin-4 + Exendin-9-39 combined intervention group (MOD/Ex-4 + Ex-9-39). After 4 weeks of drug intervention, changes in aortic plaque were observed using Oil Red O staining and H&E staining. Flow cytometry was employed to detect the content of myeloid-derived suppressor cells (MDSCs) in bone marrow and peripheral blood. ELISA was utilized to measure the concentrations of inflammatory factors in mouse peripheral blood plasma, while RT-qPCR was employed to quantify the expression levels of inflammatory factors in the spleen. Pearson correlation analysis was conducted to assess the relationship between MDSCs and inflammatory factors.
    RESULTS: Mice in the MOD group had significantly higher body weight compared to the CON group, with a statistically significant difference (P<0.05). Following Exendin-4 intervention, body weight was reduced compared to the MOD group (P<0.05). Additionally, Exendin-4 treatment led to a significant reduction in atherosclerotic plaque compared to the MOD group (P<0.001). After Exendin-4 intervention, the proportion of MDSCs in the bone marrow was higher than in the MOD group (P<0.001), and the proportion of MDSCs in peripheral blood was significantly higher than in the MOD group (P<0.05). Further investigation revealed that Exendin-4 could regulate lipid levels in mice, decreasing concentrations of TG (P<0.01), TC (P<0.0001), and LDL-C (P<0.0001), while increasing HDL-C concentrations (P<0.01). Moreover, after Exendin-4 treatment, the level of the cytokine IL-6 in peripheral plasma was significantly lower compared to the MOD group (P<0.0001), while levels of IL-10 and TGF-β were significantly higher compared to the MOD group (P<0.0001). In the spleen, levels of the cytokines IL-10 (P<0.0001) and TGF-β (P<0.001) were significantly increased compared to the MOD group. Pearson correlation analysis showed that the proportion of MDSCs in peripheral blood was positively correlated with IL-10 and TGF-β levels in both the spleen and peripheral blood. Additionally, the proportion of MDSCs in the bone marrow was positively correlated with IL-10 and TGF-β levels in the spleen and peripheral blood.
    CONCLUSIONS: Exendin-4 alleviates the severity of atherosclerosis. This process may be achieved by promoting the secretion of myeloid-derived suppressor cells (MDSCs) in the bone marrow and peripheral blood of atherosclerotic ApoE-/- mice, regulating the ratio of inflammatory factors in the body, reducing mouse body weight, and lowering blood lipids.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:斑秃是一种自身免疫性脱发疾病,病因尚不完全清楚。虽然微量元素,血清代谢物,炎症因子与疾病有关,这些因素与斑秃之间的潜在因果关系需要进一步研究.
    方法:本研究采用孟德尔随机化(MR),利用全基因组关联研究的数据,探索15种微量元素之间的因果关系,1400种血清代谢物,91种炎性因子与斑秃。分析使用逆方差加权(IVW)方法进行,辅以各种敏感性分析,包括Cochran的Q测试,MR-Egger回归截距检验,MR-PRESSO全局测试,和遗漏分析,评估结果的稳健性。
    结果:MR分析表明,铜水平与斑秃风险之间呈负相关(比值比=0.86,95%置信区间:0.75-0.99,p=0.041)。此外,确定了15种血清代谢物和6种炎症因子与斑秃风险之间的因果关系(IVW,所有p值<0.05)。
    结论:这项研究提供了微量元素之间关系的遗传证据,血清代谢物,斑秃,强调有针对性的治疗策略和预防措施的潜在价值。未来的研究应该扩展到不同的人群,并进一步探索这些生物标志物在疾病机制中的具体作用。
    BACKGROUND: Alopecia areata is an autoimmune hair loss disorder with an incompletely understood etiology. Although trace elements, serum metabolites, and inflammatory factors are implicated in the disease, the potential causal relationships between these factors and alopecia areata require further investigation.
    METHODS: This study employed Mendelian randomization (MR), utilizing data from genome-wide association studies, to explore the causal relationships between 15 trace elements, 1400 serum metabolites, and 91 inflammatory factors and alopecia areata. The analysis was conducted using the inverse variance weighted (IVW) method complemented by various sensitivity analyses, including Cochran\'s Q test, MR-Egger regression intercept test, MR-PRESSO global test, and leave-one-out analysis, to assess the robustness of the results.
    RESULTS: MR analysis indicated a negative correlation between copper levels and the risk of developing alopecia areata (odds ratio = 0.86, 95% confidence interval: 0.75-0.99, p = 0.041). Additionally, causal relationships were identified between 15 serum metabolites and 6 inflammatory factors and the risk of alopecia areata (IVW, all p values < 0.05).
    CONCLUSIONS: This study provides genetic evidence of the relationships between trace elements, serum metabolites, and alopecia areata, underscoring the potential value of targeted therapeutic strategies and preventive measures. Future research should expand to diverse populations and further explore the specific roles of these biomarkers in the disease mechanism.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:中药健脾化瘀汤(,JPHY)可以缓解肝癌患者的癌因性疲乏。然而,其机制尚不清楚。在这项研究中,我们使用BALB/c小鼠肝癌模型研究JPHY是否通过调节Th1/Th2免疫平衡减轻癌因性疲乏;以及与IL-27/STAT1信号通路的可能关联。方法:建立小鼠肝癌疲劳模型。给小鼠灌胃生理盐水,低,中等,或高浓度的JPHY;并与JPHY腹膜内注射氟达拉滨(STAT1通路抑制剂)21天。我们记录了小鼠的一般情况,并使用评分标准和疲劳游泳测试评估疲劳。我们计算了脾脏和胸腺指数,对肝肿瘤组织进行H&E染色和免疫组化分析,观察肿瘤增殖标志物ki67。我们定量了血清和脾淋巴细胞中Th1细胞产生的IFN-γ和IL-2的分泌水平,以及Th2细胞分泌IL-4,IL-10,和IL-27在信号通路中通过ELISA分析。我们使用Western印迹分析评估了脾组织中p-STAT1和STAT1的表达水平。结果:JPHY通过上调促炎细胞因子IFN-γ和IL-2并下调抗炎细胞因子IL-4和IL-10,对小鼠模型中肝细胞癌诱导的脾肿大具有治疗作用。此外,JPHY抑制ki67表达式,减少肿瘤相关的炎症浸润,并改善癌症相关的疲劳。此外,磷酸化蛋白p-STAT1的表达下调。结论:JPHY可能通过抗炎作用和促进IL-27诱导的STAT1磷酸化来改善Th1/Th2免疫平衡,从而减轻肝癌小鼠的疲劳。
    Objective: The Chinese medicine Jianpi-Huayu decoction (, JPHY) can alleviate cancer-related fatigue in patients with liver cancer. However, its mechanism remains unclear. In this study, we used BALB/c mice with liver cancer model to investigate whether JPHY alleviates cancer-related fatigue by regulating Th1/Th2 immune balance; and the possible association with the IL-27/STAT1 signaling pathway. Methods: We established a mouse model of liver cancer fatigue. Mice were gavaged with physiological saline, low, medium, or high concentrations of JPHY respectively; and intraperitoneal injection of fludarabine (STAT1 pathway inhibitor) with JPHY for 21 days. We recorded the general condition of the mice, and assessed fatigue using scoring criteria and Exhausted Swimming Test. We calculated the spleen and thymus indices, performed H&E staining and immunohistochemical analysis on liver tumor tissues to observe the tumor proliferation marker ki67. We quantified the secretion levels of IFN-γ and IL-2 produced by Th1 cells in serum and splenic lymphocytes, as well as the secretion of IL-4, IL-10 by Th2 cells, and IL-27 in the signaling pathway through ELISA analysis. We evaluated the expression levels of p-STAT1 and STAT1 in spleen tissues using Western blot analysis. Results: JPHY exhibits a therapeutic effect on hepatocellular carcinoma-induced splenomegaly in murine models by upregulating the pro-inflammatory cytokines IFN-γ and IL-2 and downregulating the anti-inflammatory cytokines IL-4 and IL-10. Moreover, JPHY suppresses ki67 expression, reduces tumor-related inflammation infiltration, and ameliorates cancer-associated fatigue. Additionally, the expression of phosphorylated protein p-STAT1 is down-regulated. Conclusion: JPHY may improve the Th1/Th2 immune balance through its anti-inflammatory effects and promotion of IL-27-induced STAT1 phosphorylation, thereby alleviating fatigue in mice with liver cancer.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:本研究旨在探讨炎症细胞因子和淋巴细胞水平在预测COVID-19感染患者疾病进展中的预后意义。
    方法:回顾性纳入92例住院COVID-19患者作为研究对象。一般临床信息和各种指标,包括淋巴细胞计数,白细胞介素-2(IL-2),白细胞介素-6(IL-6),白细胞介素-8(IL-8),白细胞介素-10(IL-10),肿瘤坏死因子(TNF),被收集。所有患者均按照第9版COVID-19指南进行治疗。观察28天内气管插管的发生率和死亡率。
    结果:1.在分析插管影响时,多变量分析确定的年龄,免疫球蛋白,淋巴细胞,IL-6为独立危险因素。在分析对患者死亡率的影响时,多变量分析显示年龄,前白蛋白,BNP为独立危险因素。2.淋巴细胞计数和炎症因子对COVID-19患者气管插管具有预测价值。临界淋巴细胞计数值为0.91,灵敏度为38.8%,特异性为92.9%,AUC为0.687(95%CI:0.580-0.795)。IL-6的临界值为38.21,灵敏度为81%,特异性为63.3%,AUC为0.771(95%CI:0.667.872)。IL-8、IL-10和TNF的ROC曲线下面积分别为0.665、0.712和0.648。3.淋巴细胞计数和炎症因子也对COVID-19患者的死亡具有预测价值。临界淋巴细胞计数值为0.56,灵敏度为71.2%,特异性为57.5%,AUC为0.641(95%CI:0.528-0.754)。IL-6的临界值为53.05,灵敏度为75%,特异性为71.2%,AUC为0.770(95%CI:0.6690.870)。IL-8、IL-10和TNF的ROC曲线下面积分别为0.687、0.683和0.636。
    结论:炎症因子升高和淋巴细胞水平降低对预测COVID-19患者气管插管和死亡率具有预后价值。为临床医生预测疾病进展提供有价值的见解。
    OBJECTIVE: This study aims to investigate the prognostic significance of inflammatory cytokines and lymphocyte levels in predicting disease progression among patients with COVID-19 infection.
    METHODS: Ninety-two hospitalized COVID-19 patients were retrospectively included as subjects for this study. General clinical information and various indicators, including lymphocyte count, interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), tumor necrosis factor (TNF), were collected. All patients received treatment according to the ninth edition of the guidelines for COVID-19. Incidences of endotracheal intubation and mortality within 28 days were observed.
    RESULTS: 1.In the analysis of intubation impact, multivariate analysis identified age, immunoglobulins, lymphocytes, and IL-6 as independent risk factors. When analyzing the impact on patient mortality, multivariate analysis revealed age, prealbumin, and BNP as independent risk factors. 2. Lymphocyte count and inflammatory factors demonstrated predictive value for endotracheal intubation in COVID-19 patients. The critical lymphocyte count value was 0.91, with a sensitivity of 38.8%, specificity of 92.9%, and AUC of 0.687 (95% CI: 0.580-0.795). The critical IL-6 value was 38.21, with a sensitivity of 81%, specificity of 63.3%, and AUC of 0.771 (95% CI: 0.6670.872). The area under the ROC curve for IL-8, IL-10 and TNF is 0.665, 0.712 and 0.648, respectively. 3.Lymphocyte count and inflammatory factors also exhibited predictive value for death in COVID-19 patients. The critical lymphocyte count value was 0.56, with a sensitivity of 71.2%, specificity of 57.5%, and AUC of 0.641 (95% CI: 0.528-0.754). The critical IL-6 value was 53.05, with a sensitivity of 75%, specificity of 71.2%, and AUC of 0.770 (95% CI: 0.6690.870). The area under the ROC curve for IL-8, IL-10 and TNF is 0.687, 0.683 and 0.636, respectively.
    CONCLUSIONS: Elevated inflammatory factors and decreased lymphocyte levels have prognostic value for predicting endotracheal intubation and mortality in COVID-19 patients, providing valuable insights for clinicians in anticipating disease progression.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    非酒精性脂肪性肝病(NAFLD)已成为发达国家的第一大慢性肝病。10-20%的NAFLD患者将发展为非酒精性脂肪性肝炎(NASH),高达25%的NASH患者可能在10年内发展为肝硬化。因此,找到可以治疗这种疾病的关键靶标至关重要。这里,我们通过分析基因表达Omnibus(GEO)数据库确定C5aR1为NASH小鼠模型中的高表达基因,并证实其在NASH患者肝脏中的表达高于NAFL患者.同时,我们验证了其与患者血清丙氨酸转氨酶(ALT)和天冬氨酸转氨酶(AST)水平呈正相关。体内和体外实验表明,敲低肝脏C5aR1可显著降低NASH小鼠肝脏重量比和血清ALT和AST水平,减轻肝脏炎症细胞浸润和细胞凋亡,增强肝脏巨噬细胞的有效增殖能力,提示C5aR1可能在肝巨噬细胞的胞增殖中起关键作用。此外,我们还发现,核苷酸结合寡聚化结构域样受体家族含Pyrin结构域蛋白3(NLRP3)的表达水平,肝组织中caspase-1、IL-1β等炎症相关因子明显减少。我们的工作证明了C5aR1缺乏症如何通过协调炎症因子的调节和影响肝巨噬细胞的红细胞增多来保护饮食诱导的NASH的潜在机制。
    Non-alcoholic fatty liver disease (NAFLD) has become the first major chronic liver disease in developed countries. 10-20% of NAFLD patients will progress to non-alcoholic steatohepatitis (NASH), and up to 25% of NASH patients may develop cirrhosis within 10 years. Therefore, it is critical to find key targets that may treat this disease. Here, we identified C5aR1 as a highly-expressed gene in NASH mouse model through analyzing Gene Expression Omnibus (GEO) database and confirmed its higher expression in livers of NASH patients than that of NAFL patients. Meanwhile, we verified its positive correlation with patients\' serum alanine transaminase (ALT) and aspartate transaminase (AST) levels. In vivo and in vitro experiments revealed that knocking down C5aR1 in liver significantly reduced liver weight ratio and serum ALT and AST levels and attenuated inflammatory cell infiltration and cell apoptosis in the liver of NASH mice as well as enhanced the efferocytotic ability of liver macrophages, suggesting that C5aR1 may play a crucial role in the efferocytosis of liver macrophages. Furthermore, we also found that the expression levels of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 (NLRP3), caspase-1, IL-1β and other inflammation-related factors in the liver were significantly reduced. Our work demonstrates a potential mechanism of how C5aR1 deficiency protects against diet-induced NASH by coordinating the regulation of inflammatory factors and affecting hepatic macrophage efferocytosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    尽管有报道表明肥胖与圆锥角膜之间存在联系,因果关系尚未完全理解。
    我们使用来自公共数据库的全基因组关联研究(GWAS)数据进行双样本孟德尔随机化分析,以调查体重指数(BMI)与圆锥角膜之间的因果关系。主要方法是方差逆加权(IVW),辅以不同的分析技术和敏感性分析,以确保结果的稳健性。还进行了荟萃分析以支持研究结果的可靠性。
    我们的研究发现BMI与圆锥角膜之间存在显著的因果关系。在进行的20次孟德尔随机化(MR)分析中,9显示异质性或多效性。在满足所有三个MR假设的11项分析中,4表明BMI和圆锥角膜之间存在显着因果关系,其余7例呈正趋势,但无统计学意义。Meta分析证实BMI与圆锥角膜之间存在显著的因果关系。
    BMI与圆锥角膜之间存在显著的因果关系,表明肥胖可能是圆锥角膜的危险因素。
    UNASSIGNED: Despite reports suggesting a link between obesity and keratoconus, the causal relationship is not fully understood.
    UNASSIGNED: We used genome-wide association study (GWAS) data from public databases for a two-sample Mendelian randomization analysis to investigate the causal link between body mass index (BMI) and keratoconus. The primary method was inverse variance weighted (IVW), complemented by different analytical techniques and sensitivity analyses to ensure result robustness. A meta-analysis was also performed to bolster the findings\' reliability.
    UNASSIGNED: Our study identified a significant causal relationship between BMI and keratoconus. Out of 20 Mendelian randomization (MR) analyses conducted, 9 showed heterogeneity or pleiotropy. Among the 11 analyses that met all three MR assumptions, 4 demonstrated a significant causal difference between BMI and keratoconus, while the remaining 7 showed a positive trend but were not statistically significant. Meta-analysis confirmed a significant causal relationship between BMI and keratoconus.
    UNASSIGNED: There is a significant causal relationship between BMI and keratoconus, suggesting that obesity may be a risk factor for keratoconus.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    分析CO2点阵激光联合复方倍他米松治疗白癜风的临床疗效及对炎症因子的影响。
    临床治疗效果,炎症因子水平[白细胞介素-17(IL-17),干扰素-γ(IFN-γ),白细胞介素-10(IL-10)],关于色素沉着和复发的预后,心理健康(满意度)。
    ①临床治疗效果:A组总有效率为92.73%,B组为74.55%,C组为67.27%,A组的有效性明显高于B组和C组(p<0.05)。②炎症因子:治疗前,IL-17、IFN-γ、和IL-10水平在三组之间(p>0.05);治疗3、6个月后,在所有三组中,IL-17和IFN-γ的水平显着降低,而IL-10水平显着升高,与B和C组相比,A组显示出更显著的变化(p<0.05)。③关于色素沉着和复发的预后:治疗3个月和6个月后,A组表现出显著高于B组和C组(p<0.05);在复发方面,A组复发率为5.45%,B组有21.82%,C组为23.64%,与B和C组相比,A组的复发率显着降低(p<0.05)。④生活质量和心理健康:6个月随访结束时,A组患者的生活质量和心理健康状况明显高于B组和C组(p<0.05)。⑤不良反应发生情况:A组不良反应发生率为12.73%,B组10.91%,丙组9.09%,三组间无显著差异(p>0.05)。
    CO2点阵激光联合复方倍他米松治疗白癜风疗效显著。与CO2点阵激光或复方倍他米松注射液单独治疗相比,这种联合方法进一步改善了白癜风患者的炎症因子水平,降低复发的风险,增强皮肤色素沉着,提高生活质量,心理健康,不会增加相关不良反应的风险。这种联合方法值得临床推广应用。
    UNASSIGNED: To analyze the clinical efficacy of CO2 fractional laser combined with compound betamethasone in treating vitiligo and its impact on inflammatory factors.
    UNASSIGNED: The clinical treatment effects, levels of inflammatory factors [interleukin-17 (IL-17), interferon-gamma (IFN-γ), interleukin-10 (IL-10)], prognosis regarding repigmentation and relapse, psychological health (satisfaction).
    UNASSIGNED: ① Clinical treatment effects: the total effective rate in Group A was 92.73%, Group B was 74.55%, and Group C was 67.27%, with Group A showing significantly higher effectiveness than Groups B and C (p < 0.05). ② Inflammatory factors: prior to treatment, there was no significant difference in IL-17, IFN-γ, and IL-10 levels among the three groups (p > 0.05); after 3 and 6 months of treatment, the levels of IL-17 and IFN-γ decreased significantly while IL-10 levels increased significantly across all three groups, with Group A showing a more pronounced change compared to Groups B and C (p < 0.05). ③ Prognosis regarding repigmentation and relapse: after 3 and 6 months of treatment, Group A exhibited significantly higher repigmentation rates compared to Groups B and C (p < 0.05); in terms of relapse, Group A had a relapse rate of 5.45%, Group B had 21.82%, and Group C had 23.64%, with Group A showing significantly lower relapse rates compared to Groups B and C (p < 0.05). ④ Quality of life and psychological health: at the end of the 6 month follow-up, the quality of life and psychological health of patients in Group A were significantly higher than those in Groups B and C (p < 0.05). ⑤ Occurrence of adverse reactions: the incidence of adverse reactions was 12.73% in Group A, 10.91% in Group B, and 9.09% in Group C, with no significant difference observed among the three groups (p > 0.05).
    UNASSIGNED: The application of CO2 fractional laser combined with compound betamethasone in vitiligo patients demonstrates significant efficacy. Compared to sole treatment with CO2 fractional laser or compound betamethasone injections, this combined approach further improves the levels of inflammatory factors in vitiligo patients, reduces the risk of relapse, enhances skin repigmentation, improves quality of life, psychological well-being, without increasing the risk of related adverse reactions. This combined approach merits clinical promotion and application.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号